Generate Biomedicines IPO highlights AI-driven drug discovery, strong backing, promising pipeline, and investor confidence signals.
Certain people in government are getting rich off of the way that the government has been reshaped and reformed in the last year," said Faith Williams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results